These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35866293)

  • 1. Identification of prediagnostic metabolites associated with prostate cancer risk by untargeted mass spectrometry-based metabolomics: A case-control study nested in the Northern Sweden Health and Disease Study.
    Östman JR; Pinto RC; Ebbels TMD; Thysell E; Hallmans G; Moazzami AA
    Int J Cancer; 2022 Dec; 151(12):2115-2127. PubMed ID: 35866293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
    Röhnisch HE; Kyrø C; Olsen A; Thysell E; Hallmans G; Moazzami AA
    BMC Med; 2020 Jul; 18(1):187. PubMed ID: 32698845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
    Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
    Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification.
    Zoni E; Minoli M; Bovet C; Wehrhan A; Piscuoglio S; Ng CKY; Gray PC; Spahn M; Thalmann GN; Kruithof-de Julio M
    BMC Cancer; 2019 Dec; 19(1):1216. PubMed ID: 31842810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma metabolites associated with type 2 diabetes in a Swedish population: a case-control study nested in a prospective cohort.
    Shi L; Brunius C; Lehtonen M; Auriola S; Bergdahl IA; Rolandsson O; Hanhineva K; Landberg R
    Diabetologia; 2018 Apr; 61(4):849-861. PubMed ID: 29349498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of circulating metabolic signature of erythrodermic psoriasis based on LC-MS metabolomics.
    Guo L; Wu C; Song B; Jin HZ
    Exp Dermatol; 2024 May; 33(5):e15103. PubMed ID: 38794829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the metabolic signatures of prostate cancer by mass spectrometry-based plasma and urine metabolomics analysis.
    Yu C; Niu L; Li L; Li T; Duan L; He Z; Zhao Y; Zou L; Wu X; Luo C
    Prostate; 2021 Dec; 81(16):1320-1328. PubMed ID: 34590739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone.
    Xu B; Chen Y; Chen X; Gan L; Zhang Y; Feng J; Yu L
    Front Oncol; 2021; 11():730638. PubMed ID: 34722271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS.
    Lu Y; Wang Y; Ong CN; Subramaniam T; Choi HW; Yuan JM; Koh WP; Pan A
    Diabetologia; 2016 Nov; 59(11):2349-2359. PubMed ID: 27514531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma metabolites associated with healthy Nordic dietary indexes and risk of type 2 diabetes-a nested case-control study in a Swedish population.
    Shi L; Brunius C; Johansson I; Bergdahl IA; Lindahl B; Hanhineva K; Landberg R
    Am J Clin Nutr; 2018 Sep; 108(3):564-575. PubMed ID: 30060042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of fatty acids in prostate cancer determined by GC-MS analysis of formalin-fixed paraffin-embedded tissue samples.
    Buszewska-Forajta M; Raczak-Gutknecht J; Artymowicz M; Wesołowski W; Buczkowski K; Iżycka-Świeszewska E; Markuszewski MJ
    J Pharm Biomed Anal; 2021 Mar; 196():113907. PubMed ID: 33497978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic signatures and risk of sarcopenia in suburb-dwelling older individuals by LC-MS-based untargeted metabonomics.
    Han P; Chen X; Liang Z; Liu Y; Yu X; Song P; Zhao Y; Zhang H; Zhu S; Shi X; Guo Q
    Front Endocrinol (Lausanne); 2024; 15():1308841. PubMed ID: 38962681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum metabolomics study of women with different annual decline rates of anti-Müllerian hormone: an untargeted gas chromatography-mass spectrometry-based study.
    Moslehi N; Mirmiran P; Marzbani R; Rezadoost H; Mirzaie M; Azizi F; Tehrani FR
    Hum Reprod; 2021 Feb; 36(3):721-733. PubMed ID: 33320198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Metabolomic Profiles and Risk of Advanced and Fatal Prostate Cancer.
    Wang Y; Jacobs EJ; Carter BD; Gapstur SM; Stevens VL
    Eur Urol Oncol; 2021 Feb; 4(1):56-65. PubMed ID: 31378665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nested case-control study of untargeted plasma metabolomics and lung cancer among never-smoking women within the prospective Shanghai Women's Health Study.
    Rahman ML; Shu XO; Jones DP; Hu W; Ji BT; Blechter B; Wong JYY; Cai Q; Yang G; Gao YT; Zheng W; Rothman N; Walker D; Lan Q
    Int J Cancer; 2024 Aug; 155(3):508-518. PubMed ID: 38651675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
    Gu Y; Zang P; Li J; Yan Y; Wang J
    Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS-based untargeted metabolomics reveals the mechanism underlying prostate damage in a type 2 diabetes mouse model.
    Qi R; Kang SS; Pei Y; Liu M; Zhou Y; Guan B; Zhang X; Li Z; Cao F
    Reprod Biol; 2023 Dec; 23(4):100811. PubMed ID: 37660522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Metabolomics and Lipidomics Profiling of Prostate Cancer Tissue Reveals Metabolic Dysregulations Associated with Disease Development.
    Lima AR; Carvalho M; Aveiro SS; Melo T; Domingues MR; Macedo-Silva C; Coimbra N; Jerónimo C; Henrique R; Bastos ML; Guedes de Pinho P; Pinto J
    J Proteome Res; 2022 Mar; 21(3):727-739. PubMed ID: 34813334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Prostate Cancer Noninvasive Biomarker Screening Using Segmented Flow Mass Spectrometry-Based Untargeted Metabolomics.
    Pinto FG; Mahmud I; Harmon TA; Rubio VY; Garrett TJ
    J Proteome Res; 2020 May; 19(5):2080-2091. PubMed ID: 32216312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GC-MS-based metabolomics reveals new biomarkers to assist the differentiation of prostate cancer and benign prostatic hyperplasia.
    Wang W; He Z; Kong Y; Liu Z; Gong L
    Clin Chim Acta; 2021 Aug; 519():10-17. PubMed ID: 33831421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.